李洪君, 吴令英, 俞高志, 张蓉, 李晓光. 子宫内膜癌腹膜后淋巴结多点活检的临床意义[J]. 中国肿瘤临床, 2004, 31(18): 1047-1050.
引用本文: 李洪君, 吴令英, 俞高志, 张蓉, 李晓光. 子宫内膜癌腹膜后淋巴结多点活检的临床意义[J]. 中国肿瘤临床, 2004, 31(18): 1047-1050.
Li Hong-jun, Wu Ling-yeng, Yu Gao-zhi, . The Clinical Value of Multiple Sites Biopsy in Retroperitoneal Lymph Nodes of Endometrial Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(18): 1047-1050.
Citation: Li Hong-jun, Wu Ling-yeng, Yu Gao-zhi, . The Clinical Value of Multiple Sites Biopsy in Retroperitoneal Lymph Nodes of Endometrial Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(18): 1047-1050.

子宫内膜癌腹膜后淋巴结多点活检的临床意义

The Clinical Value of Multiple Sites Biopsy in Retroperitoneal Lymph Nodes of Endometrial Carcinoma

  • 摘要: 目的:探讨子宫内膜癌腹膜后淋巴结多点活检的临床意义。方法:对本院1990年1月~2000年12月初次手术时行腹膜后淋巴结活检的165例子宫内膜癌患者进行回顾性分析。比较各种临床病理因素的腹膜后淋巴结转移率,淋巴结转移与无转移及不同转移数目的5年生存率。结果:165例腹膜后淋巴结多点活检中,21例病理证实淋巴结转移,5年生存率23.81%,中位生存期30.20个月,与无淋巴结转移107例(随访5年以上),5年生存率66.36%,中位生存77.30个月,两者比较(P<0.001)。淋巴结转移≤3枚10例,5年生存率50.00%,中位生存42.10个月与淋巴结转移≥4枚11例,无5年生存,中位生存期21.30个月,两者相比(P<0.001)。经单因素分析,临床分期、组织类型、病理分级、肌层浸润深度、宫颈浸润、宫旁浸润及附件浸润、淋巴血管瘤栓与腹膜后淋巴结转移有关(P<0.05),经多因素相关分析,此8个变量间比较,差异有显著性(P<0.05)。结论:腹膜后淋巴结多点活检能使手术病理分期更准确,是子宫内膜癌预后的重要因素之一,临床I、II期子宫内膜癌手术应常规行腹膜后淋巴结多点活检。

     

    Abstract: Objective : To study the practical value of multiple sites biopsy in lymph nodes of endometrial carcinoma. Methods : One hundred and sixty-five patients with endometrial carcinoma, who accepted the multiple sites biopsy in retroperitoneal lymph nodes after undergoing primary surgical treatments in our hospital from January 1990 to December 2000, were analyzed retrospectively. The metastasis rates of retroperitoneal lymph nodes with different clinical pathologic characteristics, the overall 5-year survival rates with or without lymph nodes metastasis, as well as with different numbers of positive lymph nodes among the patients, were compared. Results : The enlarged lymph nodes were palpated in forty of the one hundred and sixty-five patients. There was a significant difference between sixteen patients with metastasis about 76.19% (16/21) and twenty four patients with no metastasis account for 16.55% (24/144) (P<0.001). The patients who positive lymph nodes without enlarged take up 4.00% (5/125). in 21 patients with positive retroperitoneal lymph nodes, The 5-year survival rates was 23.81%, the median survival was 30.2 months and in 165 patients with negative lymph (who were followed up more than 5 years). The overall 5-year survival rate was 66.36%, the median survival was 77.3 months. The survival rates between patients with positive and negative lymph nodes compared showed significant difference (P<0.001). Ten patients possessed less than or equal to three of positive lymph nodes, their overall 5-year survival rates was 50.00%, the median survival were 42.1 months,while 11 patients possessed more than or equal to four of positive lymph nodes, no 5-year survival, the median survival were 21.3 months, comparing two group with different numbers of positive lymph nodes show significant difference (P<0.001). bv univariate analysis, clinical stages, histological types, patho-logical grades, depth of myometrial invasions, cervical invasions, parametrial and appendix invasions as well as lymphovascular invasions related to retroperitoneal lymph nodes positive (P<0.05), those eight factors were significantly correlated to lymph nodes positive multivariate analysis (P<0.05). Conclusion :The surgical-pathological staging is more accurate in multiple sites of retroperitoneal lymph nodes biopsy which is one of important prognostic factors, the retroperitoneal lymph nodes in multiple sites biopsy can be completed by i t routine in stages I and II for endometrial carcinoma.

     

/

返回文章
返回